Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Olivier Govaere

Newcastle AuthorsTitleYearFull text
Professor Ann Daly
Dr Olivier Govaere
Dr Simon Cockell
Professor Quentin Anstee
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis2024
Dr Olivier Govaere
Dr Megan Hasoon
Dr Simon Cockell
Dr Dina Tiniakos
Professor Ann Daly
et al.		A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures2023
Dr Olivier Govaere
Professor Ann Daly
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate2023
Dr Olivier Govaere
Professor Quentin Anstee
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease2023
Dr Kate Hallsworth
Jadine Scragg
Dr Leah Avery
Laura Haigh
Dr Olivier Govaere
et al.		Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease2023
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.		Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?2022
Dr Katherine Johnson
Dr Peter Leary
Dr Olivier Govaere
Dr Matthew Barter
Sarah Charlton
et al.		Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance2022
Dr Olivier Govaere
Dr Rebecca Darlay
Dr Julien Peltier
Dr Jeremy Palmer
Dr Massimo Younes
et al.		Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease2022
Dr Olivier Govaere
Professor Ann Daly
Professor Quentin Anstee
Metabolic signatures across the full spectrum of nonalcoholic fatty liver disease2022
Dr Sam Tingle
Dr Emily Thompson
Lucy Bates
Dr Ibra Al-Naseri
Dr Olivier Govaere
et al.		Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers2022
Dr Olivier Govaere
Professor Ann Daly
Professor Quentin Anstee
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease2022
Dr Marco Zaki
Dr Sari Alhasan
Dr Ruchi Shukla
Misti McCain
Maja Laszczewska
et al.		Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?2022
Dr Massimo Younes
Rachel Burgoyne
Dr Dina Tiniakos
Dr Olivier Govaere
Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease2021
Marco Zaki
Dr Ahmed Mahdi
Dr Gillian Patman
Anna Whitehead
Joao Mauricio
et al.		Key features of the environment promoting liver cancer in the absence of cirrhosis2021
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Youssef William Zaki
et al.		Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease2021
1234